Radiotherapy Induced Oral Mucositis Treatment Market
Radiotherapy Induced Oral Mucositis Treatment Market Forecasts to 2030 - Global Analysis By Treatment Type (Topical Agents, Systemic Agents and Medical Devices), Radiotherapy Type, Severity of Oral Mucositis, End User and By Geography
According to Stratistics MRC, the Global Radiotherapy Induced Oral Mucositis Treatment Market is accounted for $5.15 billion in 2023 and is expected to reach $7.44 billion by 2030 growing at a CAGR of 5.4% during the forecast period. Radiotherapy-induced oral mucositis (RIOM) treatment typically involves a multifaceted approach aimed at managing symptoms and promoting healing. These may include oral hygiene measures like gentle brushing and rinsing with saline solution or prescribed mouthwashes to reduce microbial growth and alleviate pain. Radiotherapy-induced oral mucositis treatment plays a crucial role in improving patient outcomes and enhancing the tolerability of cancer therapy.
According to the World Health Organization (WHO), cancer is the second leading cause of death globally, with an estimated 9.6 million deaths in 2018 and over 400,000 people in the US are estimated to receive an oral mucositis diagnosis each year.
Market Dynamics:
Driver:
Expanding geriatric population
With age, individuals become more susceptible to oral complications from radiotherapy, exacerbating the need for targeted solutions. RIOM can significantly impact the quality of life for elderly patients undergoing cancer treatment. As this demographic continues to grow, there is a pressing need for innovative therapies that alleviate RIOM symptoms, such as pain and difficulty in eating and speaking, thus highlighting the importance of advancing treatments tailored to meet the needs of older patients, thereby, driving the market growth.
Restraint:
Limited awareness
Limited awareness about the management and prevention of RIOM can hinder effective treatment. Patients may not recognize early symptoms or understand the importance of preventive measures, leading to delayed intervention and exacerbation of symptoms. Without proper education and awareness, patients may not adhere to prescribed treatments or lifestyle modifications, further complicating the management of RIOM and potentially compromising treatment outcomes.
Opportunity:
Rising healthcare expenditure
Rising healthcare expenditure drives demand for effective treatments like RIOM treatment due to its prevalence in cancer patients undergoing radiation therapy. With healthcare budgets expanding, there's greater investment in innovative therapies addressing RIOM's debilitating effects, such as pain and difficulty eating. This increased funding facilitates research into novel treatment modalities. Consequently, healthcare providers are more inclined to adopt these solutions, bolstering the market for RIOM treatment options and driving further advancements in patient care within oncology settings.
Threat:
Inadequate healthcare infrastructure
Inadequate healthcare infrastructure poses significant challenges to effective treatment of RIOM. Limited access to specialized healthcare facilities and trained personnel can delay diagnosis and intervention. Insufficient resources may lead to shortages of essential medications and equipment necessary for managing RIOM symptoms, such as pain relievers and oral hygiene products. Additionally, inadequate infrastructure may hinder patient education and follow-up care, reducing the overall quality of treatment outcomes.
Covid-19 Impact
The covid-19 pandemic has significantly impacted the RIOM treatment market. Delays in cancer diagnoses and treatments, along with disruptions in healthcare services, have led to reduced patient volumes and procedural postponements, affecting the demand for RIOM treatments. Additionally, stringent infection control measures and resource reallocations within healthcare facilities have further impeded market growth. However, advancements in telemedicine and homecare solutions have emerged as potential strategies to mitigate these challenges, facilitating continued access to RIOM treatment options amidst the pandemic.
The brachytherapy segment is expected to be the largest during the forecast period
The brachytherapy segment is estimated to have a lucrative growth. Brachytherapy, a form of radiotherapy, is emerging as a promising treatment for radiotherapy induced oral mucositis. Brachytherapy delivers targeted radiation directly to the affected area, minimizing damage to surrounding healthy tissue. As a result, it shows potential in reducing the severity of RIOM symptoms and improving patient quality of life. Its efficacy and precision make it a significant contender in the evolving landscape of RIOM treatment modalities.
The cancer treatment centers segment is expected to have the highest CAGR during the forecast period
The cancer treatment centers segment is anticipated to witness the highest CAGR growth during the forecast period. Radiotherapy-induced oral mucositis treatment in cancer treatment centers typically involves a multifaceted approach aimed at managing pain, preventing infection, and promoting healing. Additionally, advanced techniques like low-level laser therapy or cryotherapy may be employed to reduce inflammation and promote tissue repair. The goal is to mitigate symptoms, maintain oral hygiene, and improve the patient's quality of life during cancer treatment.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to rising cancer incidence and advancements in radiotherapy techniques. Moreover, supportive government initiatives and improving healthcare infrastructure are fostering market development. Key players are focusing on strategic collaborations and product innovations to gain a competitive edge. Overall, the Asia Pacific radiotherapy induced oral mucositis treatment market is poised for continuous growth in the foreseeable future.
Region with highest CAGR:
Europe is projected to have the highest CAGR over the forecast period, owing to high prevalence of cancer, advanced healthcare infrastructure, and technological advancements. The market sees significant investments in innovative radiotherapy technologies in the region. Moreover, favourable reimbursement policies and a strong presence of key market players contribute to market growth. Increasing awareness about the efficacy of radiotherapy as a treatment option for various cancers, further fuels demand.
Key players in the market
Some of the key players profiled in the Radiotherapy Induced Oral Mucositis Treatment Market include The 3M Company, GlaxoSmithKline PLC, Sun Pharmaceutical Industries Limited, Fagron Group BV, Pfizer Inc., Merck & Co. Inc., Eusa Pharma, Valeant Pharmaceuticals International Inc., Eisai Corporation, Amgen Inc., Galera Therapeutics Inc., EpicentRx, Soligenix Inc., Cellceutix Corporation and GI Solutions Group.
Key Developments:
In March 2023, EpicentRx announced that the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to RRx-001, a direct NLRP3 inhibitor and Nrf2 upregulator with anti-inflammatory and antioxidant properties, for the prevention/attenuation of severe oral mucositis in chemotherapy and radiation-treated head & neck cancer patients.
In February 2023, Galera Therapeutics announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and granted priority review to the New Drug Application (NDA) for avasopasem manganese for radiotherapy (RT)-induced severe oral mucositis (SOM) in patients with head and neck cancer (HNC) undergoing standard-of-care treatment.
Treatment Types Covered:
• Topical Agents
• Systemic Agents
• Medical Devices
Radiotherapy Types Covered:
• External Beam Radiation Therapy (EBRT)
• Intensity-Modulated Radiation Therapy (IMRT)
• Brachytherapy
• Proton Therapy
• Stereotactic Radiosurgery (SRS)
• Other Radiotherapy Types
Severity of Oral Mucositis Covered:
• Mild
• Moderate
• Severe
• Life-threatening
End Users Covered:
• Hospitals
• Cancer Treatment Centers
• Ambulatory Surgical Centers
• Research Institutes
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Radiotherapy Induced Oral Mucositis Treatment Market, By Treatment Type
5.1 Introduction
5.2 Topical Agents
5.2.1 Analgesics
5.2.2 Antimicrobial Mouthwash
5.2.3 Anesthetics
5.2.4 Coating Agents
5.3 Systemic Agents
5.3.1 Pain Management Drugs
5.3.2 Growth Factors
5.4 Medical Devices
5.4.1 Low-Level Laser Therapy (LLLT)
5.4.2 Oral Cryotherapy Devices
6 Global Radiotherapy Induced Oral Mucositis Treatment Market, By Radiotherapy Type
6.1 Introduction
6.2 External Beam Radiation Therapy (EBRT)
6.3 Intensity-Modulated Radiation Therapy (IMRT)
6.4 Brachytherapy
6.5 Proton Therapy
6.6 Stereotactic Radiosurgery (SRS)
6.7 Other Radiotherapy Types
7 Global Radiotherapy Induced Oral Mucositis Treatment Market, By Severity of Oral Mucositis
7.1 Introduction
7.2 Mild
7.3 Moderate
7.4 Severe
7.5 Life-threatening
8 Global Radiotherapy Induced Oral Mucositis Treatment Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Cancer Treatment Centers
8.4 Ambulatory Surgical Centers
8.5 Research Institutes
8.6 Other End Users
9 Global Radiotherapy Induced Oral Mucositis Treatment Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 The 3M Company
11.2 GlaxoSmithKline PLC
11.3 Sun Pharmaceutical Industries Limited
11.4 Fagron Group BV
11.5 Pfizer Inc.
11.6 Merck & Co. Inc.
11.7 Eusa Pharma
11.8 Valeant Pharmaceuticals International Inc.
11.9 Eisai Corporation
11.10 Amgen Inc.
11.11 Galera Therapeutics Inc.
11.12 EpicentRx
11.13 Soligenix Inc.
11.14 Cellceutix Corporation
11.15 GI Solutions Group
List of Tables
1 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Region (2021-2030) ($MN)
2 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
3 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Topical Agents (2021-2030) ($MN)
4 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Analgesics (2021-2030) ($MN)
5 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Antimicrobial Mouthwash (2021-2030) ($MN)
6 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Anesthetics (2021-2030) ($MN)
7 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Coating Agents (2021-2030) ($MN)
8 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Systemic Agents (2021-2030) ($MN)
9 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Pain Management Drugs (2021-2030) ($MN)
10 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Growth Factors (2021-2030) ($MN)
11 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Medical Devices (2021-2030) ($MN)
12 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Low-Level Laser Therapy (LLLT) (2021-2030) ($MN)
13 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Oral Cryotherapy Devices (2021-2030) ($MN)
14 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Radiotherapy Type (2021-2030) ($MN)
15 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By External Beam Radiation Therapy (EBRT) (2021-2030) ($MN)
16 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Intensity-Modulated Radiation Therapy (IMRT) (2021-2030) ($MN)
17 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Brachytherapy (2021-2030) ($MN)
18 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Proton Therapy (2021-2030) ($MN)
19 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Stereotactic Radiosurgery (SRS) (2021-2030) ($MN)
20 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Other Radiotherapy Types (2021-2030) ($MN)
21 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Severity of Oral Mucositis (2021-2030) ($MN)
22 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Mild (2021-2030) ($MN)
23 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Moderate (2021-2030) ($MN)
24 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Severe (2021-2030) ($MN)
25 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Life-threatening (2021-2030) ($MN)
26 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By End User (2021-2030) ($MN)
27 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
28 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Cancer Treatment Centers (2021-2030) ($MN)
29 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
30 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Research Institutes (2021-2030) ($MN)
31 Global Radiotherapy Induced Oral Mucositis Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
